WW WW International Inc.

WW International, Inc. Announces Participation in Upcoming Investor Conferences

WW International, Inc. Announces Participation in Upcoming Investor Conferences

NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced that it will present at the following investor conferences.

Baird 2023 Global Healthcare Conference

Tuesday, September 12, 2023 at 4:55 pm ET

New York, NY

Presenters: Heather Stark, Chief Financial Officer and Gary Foster, PhD, Chief Scientific Officer

Morgan Stanley 21st Annual Global Healthcare Conference

Wednesday, September 13, 2023 at 3:35 pm ET

New York, NY

Presenters: Sima Sistani, Chief Executive Officer and Heather Stark, Chief Financial Officer

The presentations will be accessible via live audio webcast on the Company's corporate website at in the Investors section under Presentations and Events. An archive of the webcasts will be available on this site for 30 days.

About WW International, Inc.

WeightWatchers is a human-centric technology company powered by our proven, science-based, clinically effective weight loss and weight management program. For six decades, we have inspired millions of people to adopt healthy habits for real life. We combine technology and community to help members reach and sustain their goals on our program. To learn more about the WeightWatchers approach to healthy living, please visit . For more information about our global business, visit our corporate website at .

For more information, contact:

Corey Kinger



EN
08/09/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on WW International Inc.

 PRESS RELEASE

WeightWatchers Completes Financial Reorganization, Strengthens Leaders...

WeightWatchers Completes Financial Reorganization, Strengthens Leadership, and Expands Program Innovation to Support Women Through Menopause With renewed financial strength, WeightWatchers accelerates its transformation with the appointment of key executives including Dr. Kim Boyd as Chief Medical Officer The Company is advancing its first integrated women’s health initiative focused on perimenopause and menopause, combining medical, nutritional, lifestyle, and community-based support WeightWatchers successfully relists as a public company on Nasdaq under ticker WW NEW YORK, July 08, 20...

 PRESS RELEASE

WeightWatchers and Novo Nordisk Expand Collaboration to Improve Medica...

WeightWatchers and Novo Nordisk Expand Collaboration to Improve Medication Access Through Trusted, Holistic Model of Care WeightWatchers Clinic Members Can Access FDA-Approved Wegovy® for $299 in July, a $200 Savings Offer to Improve Access as WeightWatchers’ Trusted, Science-Backed Approach Continues to Lead the Industry Collaboration Builds a Seamless NovoCare® Pharmacy Integration, Shared Vision to Enhance Outcomes Through WW’s GLP-1 Companion Support, and a Commitment to Publishing Real-World Evidence WeightWatchers Sets the Standard in Evidence-Based Weight Health, Prescribing Only ...

 PRESS RELEASE

WeightWatchers’ Reorganization Plan Confirmed, Clears Path for Elimina...

WeightWatchers’ Reorganization Plan Confirmed, Clears Path for Elimination of Majority of Legacy Debt Burden and Execution of Transformation Plan On Track to Exit Financial Reorganization Process Next Week, Company to Focus on Scaled Delivery of Its Comprehensive, Best-in-Class Weight Management Platform, Integrating Community, Behavioral, and Medical Solutions NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- WW International, Inc., the global leader in science-backed weight management (“WeightWatchers” or the “Company”), today announced that, following approval of its Plan of Reorganization...

 PRESS RELEASE

CheqUp and WeightWatchers Announce Strategic Partnership to Support Gr...

CheqUp and WeightWatchers Announce Strategic Partnership to Support Growing Use of GLP-1 Medications in the UK Partnership Provides CheqUp Members Access to WeightWatchers’ Proven GLP-1 Companion Programme to Aid in Achieving Superior and Sustainable Results CHIPPENHAM, England, May 22, 2025 (GLOBE NEWSWIRE) -- , one of the UK’s leading providers of GLP-1 based weight loss services, and , the global leader in science-backed weight management, have announced a partnership that will combine the offerings of both organizations to benefit patients seeking sustainable weight loss through GLP...

 PRESS RELEASE

WeightWatchers Takes Strategic Action to Eliminate $1.15 Billion of De...

WeightWatchers Takes Strategic Action to Eliminate $1.15 Billion of Debt, Strengthening Financial Position for Long-Term Growth and Profitability Operations continue with no impact to its more than three million members worldwide Positions the Company to execute its transformation strategy, focused on enhancing its digital and member experience and expanding its telehealth business which achieved 57% year-over-year revenue growth in Q1 2025 Enters comprehensive agreement with lenders and noteholders to significantly reduce its debt obligations and bolster financial flexibility ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch